Davis AJ (2026). [PMID: 42264414](https://pubmed.ncbi.nlm.nih.gov/42264414/). *Semin Ultrasound CT MR*. [Review / Meta-Analysis]
Yi X (2026). [PMID: 42222383](https://pubmed.ncbi.nlm.nih.gov/42222383/). *Front Oncol*. [Case Report / Case Series]
Put A (2026). [PMID: 41854102](https://pubmed.ncbi.nlm.nih.gov/41854102/). *Cancer Rep (Hoboken)*. [Basic Science / Preclinical]
Xu P (2026). [PMID: 41768248](https://pubmed.ncbi.nlm.nih.gov/41768248/). *Front Oncol*. [Case Report / Case Series]
Matsuoka R (2026). [PMID: 41581412](https://pubmed.ncbi.nlm.nih.gov/41581412/). *Cancer Treat Res Commun*. [Basic Science / Preclinical]
von Amsberg G (2026). [PMID: 41571001](https://pubmed.ncbi.nlm.nih.gov/41571001/). *Aktuelle Urol*. [Review / Meta-Analysis]
Tsukada A (2026). [PMID: 42208366](https://pubmed.ncbi.nlm.nih.gov/42208366/). *Lung Cancer*. [Review / Meta-Analysis]
Kong YH (2026). [PMID: 42236456](https://pubmed.ncbi.nlm.nih.gov/42236456/). *Zhonghua Jie He He Hu Xi Za Zhi*. [Review / Meta-Analysis]
Pei Y (2026). [PMID: 41674993](https://pubmed.ncbi.nlm.nih.gov/41674993/). *Transl Cancer Res*. [Diagnostic / Biomarker]
Kemik F (2026). [PMID: 40626442](https://pubmed.ncbi.nlm.nih.gov/40626442/). *Anticancer Drugs*. [Review / Meta-Analysis]
